Procrit, Camptosar At Risk Under 2005 Medicare Payment Rates, ASCO Says

Medicare reimbursement rates for 2005 will not cover costs of Johnson & Johnson's Procrit (epoetin) for the majority of oncology practices, according to the American Society of Clinical Oncology